February 12, 2018, USPSTF. We agree with the USPSTF that current evidence is insufficient to assess potential benefits and harms of adding the ankle-brachial index (ABI), high-sensitivity C-reactive protein (hsCRP), or coronary artery calcification (CAC) score to the traditional risk assessments for CVD.
Read More »Heart Disease, Cholesterol & Strokes
NCHR Comments on USPSTF Draft Screening Recommendations for Peripheral Artery Disease (PAD)
USPSTF, February 12, 2018. In order to more widely recommend ABI, we need more studies directly evaluating both the efficacy and harms. Most importantly, we encourage the USPSTF to review studies that analyze the accuracy of ABI and its effect on improving health outcomes in asymptomatic PAD patients.
Read More »NCHR and WomenHeart Comments on USPSTF Draft Recommendation Statement Cardiovascular Disease Risk: Screening with Electrocardiography (ECG)
Jan 22, 2018, We commend the USPSTF for reviewing the evidence and developing evidence-based recommendations. There is substantial evidence to recommend against screening in low risk adults and is insufficient to support screening in higher risk adults.
Read More »Prevent Disability by Learning Stroke Symptoms
Strokes are the 5th leading cause of death in the United States and the #1 cause of long-term disability. Having one stroke increases the risk for having another stroke in the next year. Recognizing the early signs of stroke can save lives, prevent long-term disability, and improve quality of life.
Read More »Which Blood-Thinning Medication Is Right for You?
This article will describe the benefits and risks of different blood thinning medications for reducing the chance of stroke for those with atrial fibrillation.
Read More »